Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
Clinical trial NCT04991805 · COMPLETED
Trial details
- NCT number
- NCT04991805
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-26
- Primary completion
- 2024-04-05
- Enrollment
- 14000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.